查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2127638

2026年全球宏基因體學臨床報告市場報告

Shotgun Metagenomics Clinical Reporting Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，利用宏基因組鳥槍總體基因體學進行臨床報告的市場發展迅速。預計該市場將從2025年的15.8億美元成長到2026年的18.3億美元，複合年成長率（CAGR）為16.4%。這項成長主要歸功於以下幾個面向：次世代定序技術的進步推動了臨床應用；感染疾病疫情的增加刺激了診斷需求；微生物學和臨床基因組學研究經費的增加；醫院檢查室分子檢測基礎設施的完善；以及人們對抗菌素抗藥性監測需求的日益重視。

預計未來幾年，宏基因組學鳥槍總體基因體學臨床報告市場將快速成長，到2030年將達到34億美元，複合年成長率（CAGR）為16.7%。預測期內的成長主要歸功於精準醫療和個人化診斷的日益普及、人工智慧在基因組數據分析中應用的不斷深入、分散式和即時檢測（PoC）定序系統的擴展、重症監護環境中對快速病原體檢測需求的不斷成長，以及用於臨床工作流程的雲端生物資訊平台的擴展。預測期內的關鍵趨勢包括：人工智慧驅動的病原體檢測和自動化臨床解讀系統、用於即時診斷的雲端基因組數據共用平台、用於即時感染疾病檢測的超快速定序工作流程、利用基因組分析進行抗菌藥物抗藥性預測，以及用於醫院內快速元基因組檢測的分散式定序系統。

感染疾病的日益流行預計將推動宏基因組鳥槍總體基因體學臨床報告市場的成長。感染疾病是由細菌、病毒、真菌和寄生蟲等致病微生物引起的疾病，可透過人際傳播、動物間傳播或環境傳播。隨著全球互聯互通和人口流動的加劇，感染疾病感染疾病日益頻繁，導致其盛行率上升。利用宏基因元基因組分析的臨床報告能夠快速、全面地檢測臨床檢體中的病原體、抗菌素抗藥性標記和合併感染疾病，從而幫助醫療專業人員進行準確診斷和標靶治療，進而支持感染疾病管理。例如，根據總部位於瑞士的公共衛生機構世界衛生組織（世衛組織）的數據，截至2024年10月，2023年約有820萬人新確診結核病，比2022年的750萬人增加了約9.3%。因此，感染疾病盛行率的上升正在推動宏總體基因體學臨床報告市場的成長。

在宏元基因組臨床報告市場中，領先的公司正致力於開發先進的解決方案，例如呼吸道特異性基因組檢測板，以分析目標臨床體液中的微生物遊離DNA，並改善易感患者群體的診斷標準。呼吸道特異性基因組檢測板是元基因組定序的一種特殊應用，旨在直接從複雜的、具有特定基質的生物體液（例如肺泡灌洗液）中識別和序列測定病原體DNA片段，從而實現對複雜呼吸道感染疾病的快速、無需培養的診斷。例如，Karius公司於2025年4月推出了Karius Focus BAL，這是一種全面的元基因組定序檢測，利用支氣管肺泡灌洗液分析微生物胞外DNA。此診斷方案可直接評估液體檢體，識別500多種病原體，在接受檢體後一個自然日內提供處理後的診斷結果，並且與傳統檢測方法相比，可多檢測出50%的引起感染性肺炎的病原體。

目錄

第1章：執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球宏基因體學鳥槍法臨床報告市場：吸引力評分與分析
  • 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 清單：主要原料、資源和供應商
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章：全球市場趨勢與策略

  • 關鍵科技與未來趨勢
    • 生物技術、基因組學和精準醫療
    • 數位化、雲端運算、巨量資料、網路安全
    • 人工智慧和自主智慧
    • 工業4.0和智慧製造
    • 物聯網、智慧基礎設施、互聯生態系統
  • 主要趨勢
    • 人工智慧驅動的病原體檢測和自動化臨床診斷系統
    • 用於即時診斷的雲端基因組資料共用平台
    • 用於臨床環境中感染疾病檢測的超快速定序定序
    • 利用基因組分析進行綜合抗生素抗藥性預測
    • 一種用於醫院快速元基因組檢測的去中心化定序系統。

第5章 終端用戶產業市場分析

  • 醫院和診所
  • 診斷檢查室
  • 研究機構
  • 製藥和生物技術公司
  • 其他最終用戶

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球宏基因體學臨床報告市場：PESTEL 分析
  • 全球宏基因體學鳥槍法臨床報告市場：規模、比較與成長率分析
  • 全球宏基因體學鳥槍法臨床報告市場表現：規模與成長，2020-2025年
  • 全球宏基因體學鳥槍法臨床報告市場預測：規模與成長，2025-2030年，2035年

第8章：全球市場總規模（TAM）

第9章 市場細分

  • 依產品類型
  • 軟體、服務
  • 依樣本類型
  • 血液檢體、糞便檢體、呼吸道檢體、腦脊髓液檢體、組織切片檢查檢體、尿液檢體和其他體液檢體。
  • 依定序技術類型
  • 短讀長定定序、長讀長定定序、混合定序
  • 按應用程式類型
  • 感染疾病診斷、腫瘤學、微生物組分析、抗生素抗藥性及其他應用
  • 按最終用戶類型
  • 醫院和診所、診斷檢測實驗室、研究機構和其他終端使用者類型
  • 按類型細分：軟體
  • 資料分析與處理軟體、病原體鑑定資料庫、臨床報告產生平台、抗菌藥物抗藥性分析軟體
  • 按類型細分：服務
  • 端到端基因組診斷服務、檢體處理和次世代定序服務、生物資訊分析服務、臨床解釋和報告服務。

第10章 區域與國別分析

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 宏基因體學鳥槍法臨床報告市場：競爭格局與市場佔有率，2024 年
  • 宏基因組學臨床報告市場：公司評估矩陣
  • 宏基因體學鳥槍法臨床報告市場：公司概況
    • BaseClear BV
    • BGI Genomics Co. Ltd.
    • BugSeq Bioinformatics Inc.
    • CD Genomics Inc.
    • Cmbio

第37章 其他大型企業和創新企業

  • Eurofins Scientific, Genome Detective, Illumina Inc., Karius Inc., Macrogen Inc., Microba Life Sciences Limited, Novogene Co. Ltd., Nucleome Informatics Private Limited, Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Psomagen Inc., QIAGEN NV, Revvity Inc., Strand Life Sciences Private Limited, Synnovis Group LLP

第38章：全球市場競爭基準分析與儀錶板

第39章：預計進入市場的新創企業

第40章 重大併購

第41章 具有高市場潛力的國家、細分市場與策略

  • 2030年宏基因體學臨床報告市場：提供新機會的國家
  • 2030 年宏基因體學臨床報告市場：新興機會細分領域
  • 2030 年宏基因體學臨床報告市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第42章附錄

簡介目錄
Product Code: HS6MSMCR01_G26Q3

Shotgun metagenomics clinical reporting refers to a diagnostic methodology that utilizes next-generation sequencing to examine all genetic material contained within a clinical sample. It enables comprehensive and unbiased identification of bacteria, viruses, fungi, and parasites without requiring targeted detection of specific organisms. The sequencing results are analyzed through bioinformatics tools to identify pathogens and antimicrobial resistance markers.

The primary product types of shotgun metagenomics clinical reporting include software and services. Software refers to digital platforms developed to analyze complex metagenomic sequencing data and generate clinical reports for diagnostic and research applications. These solutions analyze sample types including blood samples, stool samples, respiratory samples, cerebrospinal fluid samples, tissue biopsy samples, urine samples, and other body fluid samples and utilize sequencing technologies such as short read sequencing, long read sequencing, and hybrid sequencing. The key applications include infectious disease diagnostics, oncology, microbiome analysis, antimicrobial resistance, and others, while the end users include hospitals and clinics, diagnostic laboratories, research institutes, and others.

Tariffs are influencing the shotgun metagenomics clinical reporting market by increasing the cost of imported sequencing instruments, reagents, and high-performance computing infrastructure required for genomic analysis. This is reducing the affordability and scalability of clinical metagenomics testing, particularly in regions dependent on global supply chains such as Asia-Pacific and Latin America. Segments including sequencing technology platforms and bioinformatics software services are the most affected due to their reliance on cross-border hardware and cloud infrastructure ecosystems. However, tariffs are also encouraging the localization of sequencing workflows, regional manufacturing of consumables, and investment in domestic genomic diagnostic capabilities, which may strengthen long-term healthcare resilience and reduce dependence on imported technologies.

The shotgun metagenomics clinical reporting market research report is one of a series of new reports from The Business Research Company that provides shotgun metagenomics clinical reporting market statistics, including shotgun metagenomics clinical reporting industry global market size, regional shares, competitors with a shotgun metagenomics clinical reporting market share, detailed shotgun metagenomics clinical reporting market segments, market trends and opportunities, and any further data you may need to thrive in the shotgun metagenomics clinical reporting industry. This shotgun metagenomics clinical reporting market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The shotgun metagenomics clinical reporting market size has grown rapidly in recent years. It will grow from $1.58 billion in 2025 to $1.83 billion in 2026 at a compound annual growth rate (CAGR) of 16.4%. The growth in the historic period can be attributed to advancement of next-generation sequencing technologies enabling clinical adoption, increasing prevalence of infectious disease outbreaks driving diagnostic demand, growth in microbiology and clinical genomics research funding, expansion of hospital laboratory molecular testing infrastructure, rising awareness of antimicrobial resistance monitoring needs.

The shotgun metagenomics clinical reporting market size is expected to see rapid growth in the next few years. It will grow to $3.4 billion in 2030 at a compound annual growth rate (CAGR) of 16.7%. The growth in the forecast period can be attributed to expansion of precision medicine and personalized diagnostics adoption, increasing integration of AI in genomic data interpretation, growth in decentralized and point-of-care sequencing systems, rising demand for rapid pathogen detection in critical care settings, expansion of cloud-based bioinformatics platforms for clinical workflows. Major trends in the forecast period include ai-driven pathogen detection and automated clinical interpretation systems, cloud-based genomic data sharing platforms for real-time diagnostics, ultra-rapid sequencing workflows for point-of-care infectious disease detection, integrated antimicrobial resistance prediction using genomic analytics, decentralized sequencing systems for hospital-based rapid metagenomic testing.

The increasing prevalence of infectious diseases is expected to drive the growth of the shotgun metagenomics clinical reporting market going forward. Infectious diseases are illnesses caused by pathogenic microorganisms, including bacteria, viruses, fungi, and parasites, which can spread among individuals, animals, or through environmental sources. The prevalence of infectious diseases is rising due to the increasing occurrence of disease outbreaks linked to greater global connectivity and population movement. Shotgun metagenomics clinical reporting supports infectious disease management by enabling rapid and comprehensive detection of pathogens, antimicrobial resistance markers, and co-infections from clinical samples, helping healthcare providers achieve accurate diagnosis and targeted treatment. For instance, in October 2024, according to the World Health Organization, a Switzerland-based public health organization, approximately 8.2 million people were newly diagnosed with tuberculosis in 2023, compared to 7.5 million people in 2022, reflecting an increase of around 9.3%. Therefore, the increasing prevalence of infectious diseases is driving the growth of the shotgun metagenomics clinical reporting market.

Major companies operating in the shotgun metagenomics clinical reporting market are focusing on the development of advanced solutions, such as respiratory-focused genomic panels, to analyze microbial cell-free DNA from targeted clinical fluids and enhance diagnostic standards for vulnerable patient populations. Respiratory-focused genomic panels are specialized applications of metagenomic sequencing designed to identify and sequence fragmented pathogen DNA directly from complex, matrix-specific biological fluids, such as lung wash samples, enabling rapid, culture-independent diagnosis of complex respiratory tract infections. For instance, in April 2025, Karius Inc. launched Karius Focus BAL, a comprehensive metagenomic sequencing test that uses bronchoalveolar lavage fluid to analyze microbial cell-free DNA. The diagnostic solution evaluates fluid samples directly to identify more than 500 pathogens, provides processed diagnostic results within one calendar day of receiving samples, and detects 50% more causes of infectious pneumonia compared to conventional testing approaches.

In April 2026, Karius Inc., a US-based infectious disease diagnostics company, partnered with Mayo Clinic Laboratories to broaden access to advanced metagenomic infectious disease testing. Through this partnership, Karius aimed to make its Karius Spectrum and Karius Focus | BAL tests available for ordering through Mayo Clinic Laboratories, enabling improved access to comprehensive pathogen detection and clinical diagnostic reporting. Mayo Clinic Laboratories is a US-based clinical laboratory services provider specializing in advanced diagnostic testing and laboratory medicine.

Major companies operating in the shotgun metagenomics clinical reporting market report are BaseClear B.V., BGI Genomics Co. Ltd., BugSeq Bioinformatics Inc., CD Genomics Inc., Cmbio, Eurofins Scientific, Genome Detective, Illumina Inc., Karius Inc., Macrogen Inc., Microba Life Sciences Limited, Novogene Co. Ltd., Nucleome Informatics Private Limited, Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Psomagen Inc., QIAGEN N.V., Revvity Inc., Strand Life Sciences Private Limited, Synnovis Group LLP, Takara Bio Inc., Thermo Fisher Scientific Inc., Yaazh Xenomics Private Limited, Zymo Research Corporation

North America was the dominating region in the shotgun metagenomics clinical reporting market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the shotgun metagenomics clinical reporting market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the shotgun metagenomics clinical reporting market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The shotgun metagenomics clinical reporting market consists of revenues earned by entities by providing services such as end-to-end genomic diagnostic services, sample processing, next-generation sequencing, bioinformatics analysis, pathogen identification, antimicrobial resistance profiling, and clinical interpretation. The market value includes the value of related goods sold by the service provider or included within the service offering. The shotgun metagenomics clinical reporting market also includes sales of benchtop dna sequencers, high-throughput sequencing systems, automated nucleic acid extraction systems, sample preparation workstations, and library preparation instruments. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Shotgun Metagenomics Clinical Reporting Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses shotgun metagenomics clinical reporting market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for shotgun metagenomics clinical reporting ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The shotgun metagenomics clinical reporting market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Software; Services
  • 2) By Sample Type: Blood Samples; Stool Samples; Respiratory Samples; Cerebrospinal Fluid Samples; Tissue Biopsy Samples; Urine Samples; Other Body Fluid Samples
  • 3) By Sequencing Technology Type: Short Read Sequencing; Long Read Sequencing; Hybrid Sequencing
  • 4) By Application Type: Infectious Disease Diagnostics; Oncology; Microbiome Analysis; Antimicrobial Resistance; Other Application Types
  • 5) By End User Type: Hospitals And Clinics; Diagnostic Laboratories; Research Institutes; Other End User Types
  • Subsegments:
  • 1) By Software: Data Analysis And Processing Software; Pathogen Identification Databases; Clinical Report Generation Platforms; Antimicrobial Resistance Profiling Software
  • 2) By Services: End To End Genomic Diagnostic Services; Sample Processing And Next Generation Sequencing Services; Bioinformatics Analysis Services; Clinical Interpretation And Reporting Services
  • Companies Mentioned: BaseClear B.V.; BGI Genomics Co. Ltd.; BugSeq Bioinformatics Inc.; CD Genomics Inc.; Cmbio; Eurofins Scientific; Genome Detective; Illumina Inc.; Karius Inc.; Macrogen Inc.; Microba Life Sciences Limited; Novogene Co. Ltd.; Nucleome Informatics Private Limited; Oxford Nanopore Technologies plc; Pacific Biosciences of California Inc.; Psomagen Inc.; QIAGEN N.V.; Revvity Inc.; Strand Life Sciences Private Limited; Synnovis Group LLP; Takara Bio Inc.; Thermo Fisher Scientific Inc.; Yaazh Xenomics Private Limited; Zymo Research Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Shotgun Metagenomics Clinical Reporting Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Shotgun Metagenomics Clinical Reporting Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Shotgun Metagenomics Clinical Reporting Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Shotgun Metagenomics Clinical Reporting Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Artificial Intelligence & Autonomous Intelligence
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 AI Driven Pathogen Detection And Automated Clinical Interpretation Systems
    • 4.2.2 Cloud Based Genomic Data Sharing Platforms For Real Time Diagnostics
    • 4.2.3 Ultra Rapid Sequencing Workflows For Point Of Care Infectious Disease Detection
    • 4.2.4 Integrated Antimicrobial Resistance Prediction Using Genomic Analytics
    • 4.2.5 Decentralized Sequencing Systems For Hospital Based Rapid Metagenomic Testing

5. Shotgun Metagenomics Clinical Reporting Market Analysis Of End Use Industries

  • 5.1 Hospitals And Clinics
  • 5.2 Diagnostic Laboratories
  • 5.3 Research Institutes
  • 5.4 Pharmaceutical And Biotechnology Companies
  • 5.5 Other End Users

6. Shotgun Metagenomics Clinical Reporting Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Shotgun Metagenomics Clinical Reporting Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Shotgun Metagenomics Clinical Reporting PESTEL Analysis (Political, Economical, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Shotgun Metagenomics Clinical Reporting Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Shotgun Metagenomics Clinical Reporting Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Shotgun Metagenomics Clinical Reporting Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Shotgun Metagenomics Clinical Reporting Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Shotgun Metagenomics Clinical Reporting Market Segmentation

  • 9.1. Global Shotgun Metagenomics Clinical Reporting Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Software, Services
  • 9.2. Global Shotgun Metagenomics Clinical Reporting Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Blood Samples, Stool Samples, Respiratory Samples, Cerebrospinal Fluid Samples, Tissue Biopsy Samples, Urine Samples, Other Body Fluid Samples
  • 9.3. Global Shotgun Metagenomics Clinical Reporting Market, Segmentation By Sequencing Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Short Read Sequencing, Long Read Sequencing, Hybrid Sequencing
  • 9.4. Global Shotgun Metagenomics Clinical Reporting Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Infectious Disease Diagnostics, Oncology, Microbiome Analysis, Antimicrobial Resistance, Other Application Types
  • 9.5. Global Shotgun Metagenomics Clinical Reporting Market, Segmentation By End User Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Other End User Types
  • 9.6. Global Shotgun Metagenomics Clinical Reporting Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Data Analysis And Processing Software, Pathogen Identification Databases, Clinical Report Generation Platforms, Antimicrobial Resistance Profiling Software
  • 9.7. Global Shotgun Metagenomics Clinical Reporting Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • End To End Genomic Diagnostic Services, Sample Processing And Next Generation Sequencing Services, Bioinformatics Analysis Services, Clinical Interpretation And Reporting Services

10. Shotgun Metagenomics Clinical Reporting Market Regional And Country Analysis

  • 10.1. Global Shotgun Metagenomics Clinical Reporting Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Shotgun Metagenomics Clinical Reporting Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Shotgun Metagenomics Clinical Reporting Market

  • 11.1. Asia-Pacific Shotgun Metagenomics Clinical Reporting Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Shotgun Metagenomics Clinical Reporting Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Sequencing Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Shotgun Metagenomics Clinical Reporting Market

  • 12.1. China Shotgun Metagenomics Clinical Reporting Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Shotgun Metagenomics Clinical Reporting Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Sequencing Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Shotgun Metagenomics Clinical Reporting Market

  • 13.1. India Shotgun Metagenomics Clinical Reporting Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Sequencing Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Shotgun Metagenomics Clinical Reporting Market

  • 14.1. Japan Shotgun Metagenomics Clinical Reporting Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Shotgun Metagenomics Clinical Reporting Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Sequencing Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Shotgun Metagenomics Clinical Reporting Market

  • 15.1. Australia Shotgun Metagenomics Clinical Reporting Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Sequencing Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Shotgun Metagenomics Clinical Reporting Market

  • 16.1. Indonesia Shotgun Metagenomics Clinical Reporting Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Sequencing Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Shotgun Metagenomics Clinical Reporting Market

  • 17.1. South Korea Shotgun Metagenomics Clinical Reporting Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Shotgun Metagenomics Clinical Reporting Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Sequencing Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Shotgun Metagenomics Clinical Reporting Market

  • 18.1. Taiwan Shotgun Metagenomics Clinical Reporting Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Shotgun Metagenomics Clinical Reporting Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Sequencing Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Shotgun Metagenomics Clinical Reporting Market

  • 19.1. South East Asia Shotgun Metagenomics Clinical Reporting Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Shotgun Metagenomics Clinical Reporting Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Sequencing Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Shotgun Metagenomics Clinical Reporting Market

  • 20.1. Western Europe Shotgun Metagenomics Clinical Reporting Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Shotgun Metagenomics Clinical Reporting Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Sequencing Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Shotgun Metagenomics Clinical Reporting Market

  • 21.1. UK Shotgun Metagenomics Clinical Reporting Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Sequencing Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Shotgun Metagenomics Clinical Reporting Market

  • 22.1. Germany Shotgun Metagenomics Clinical Reporting Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Sequencing Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Shotgun Metagenomics Clinical Reporting Market

  • 23.1. France Shotgun Metagenomics Clinical Reporting Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Sequencing Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Shotgun Metagenomics Clinical Reporting Market

  • 24.1. Italy Shotgun Metagenomics Clinical Reporting Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Sequencing Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Shotgun Metagenomics Clinical Reporting Market

  • 25.1. Spain Shotgun Metagenomics Clinical Reporting Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Sequencing Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Shotgun Metagenomics Clinical Reporting Market

  • 26.1. Eastern Europe Shotgun Metagenomics Clinical Reporting Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Shotgun Metagenomics Clinical Reporting Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Sequencing Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Shotgun Metagenomics Clinical Reporting Market

  • 27.1. Russia Shotgun Metagenomics Clinical Reporting Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Sequencing Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Shotgun Metagenomics Clinical Reporting Market

  • 28.1. North America Shotgun Metagenomics Clinical Reporting Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Shotgun Metagenomics Clinical Reporting Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Sequencing Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Shotgun Metagenomics Clinical Reporting Market

  • 29.1. USA Shotgun Metagenomics Clinical Reporting Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Shotgun Metagenomics Clinical Reporting Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Sequencing Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Shotgun Metagenomics Clinical Reporting Market

  • 30.1. Canada Shotgun Metagenomics Clinical Reporting Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Shotgun Metagenomics Clinical Reporting Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Sequencing Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Shotgun Metagenomics Clinical Reporting Market

  • 31.1. South America Shotgun Metagenomics Clinical Reporting Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Shotgun Metagenomics Clinical Reporting Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Sequencing Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Shotgun Metagenomics Clinical Reporting Market

  • 32.1. Brazil Shotgun Metagenomics Clinical Reporting Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Sequencing Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Shotgun Metagenomics Clinical Reporting Market

  • 33.1. Middle East Shotgun Metagenomics Clinical Reporting Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Shotgun Metagenomics Clinical Reporting Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Sequencing Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Shotgun Metagenomics Clinical Reporting Market

  • 34.1. Africa Shotgun Metagenomics Clinical Reporting Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Shotgun Metagenomics Clinical Reporting Market, Segmentation By Product Type, Segmentation By Sample Type, Segmentation By Sequencing Technology Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Shotgun Metagenomics Clinical Reporting Market Regulatory and Investment Landscape

36. Shotgun Metagenomics Clinical Reporting Market Competitive Landscape And Company Profiles

  • 36.1. Shotgun Metagenomics Clinical Reporting Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Shotgun Metagenomics Clinical Reporting Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Shotgun Metagenomics Clinical Reporting Market Company Profiles
    • 36.3.1. BaseClear B.V. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. BGI Genomics Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. BugSeq Bioinformatics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. CD Genomics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Cmbio Overview, Products and Services, Strategy and Financial Analysis

37. Shotgun Metagenomics Clinical Reporting Market Other Major And Innovative Companies

  • Eurofins Scientific, Genome Detective, Illumina Inc., Karius Inc., Macrogen Inc., Microba Life Sciences Limited, Novogene Co. Ltd., Nucleome Informatics Private Limited, Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Psomagen Inc., QIAGEN N.V., Revvity Inc., Strand Life Sciences Private Limited, Synnovis Group LLP

38. Global Shotgun Metagenomics Clinical Reporting Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Shotgun Metagenomics Clinical Reporting Market

41. Shotgun Metagenomics Clinical Reporting Market High Potential Countries, Segments and Strategies

  • 41.1 Shotgun Metagenomics Clinical Reporting Market In 2030 - Countries Offering Most New Opportunities
  • 41.2 Shotgun Metagenomics Clinical Reporting Market In 2030 - Segments Offering Most New Opportunities
  • 41.3 Shotgun Metagenomics Clinical Reporting Market In 2030 - Growth Strategies
    • 41.3.1 Market Trend Based Strategies
    • 41.3.2 Competitor Strategies

42. Appendix

  • 42.1. Abbreviations
  • 42.2. Currencies
  • 42.3. Historic And Forecast Inflation Rates
  • 42.4. Research Inquiries
  • 42.5. The Business Research Company
  • 42.6. Copyright And Disclaimer